Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis
Massimo Martino, President of GITMO, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Hematology Reports, adding:
”We are pleased to inform that our article ‘Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: Evolving Indications, Conditioning Strategies, and Outcomes’ has been published in Hematology Reports as part of the Special Issue Outcomes and Complications Post-Allogeneic Hematopoietic.”
Title: Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: Evolving Indications, Conditioning Strategies, and Outcomes
Authors: Caterina Alati, Stefano Botti, Francesca Cogliandro, Martina Pitea, Matteo Pacilli, Gaetana Porto, Giorgia Policastro, Annalisa Sgarlata, Maria Caterina Mico, Barbara Loteta, Laura Giordano, Giulia Santoro, Jessyca Germano, Massimo Martino
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge